)
Alamar Biosciences (ALMR) investor relations material
Alamar Biosciences Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Commercial-stage proteomics company with rapid adoption of ARGO HT and NULISA platforms, over 100 instruments installed, more than 300 customers in 25 countries as of March 31, 2026.
Revenue for Q1 2026 nearly doubled year-over-year to $26.0 million, driven by strong instrument and consumables sales and new product launches.
Two new products launched, expanding offerings in neurodegenerative disease research.
Completed IPO in April 2026, raising $197.8 million in net proceeds and approximately $220 million in gross proceeds.
Net loss increased to $21.3 million due to higher R&D and SG&A expenses as the company scales operations.
Financial highlights
Q1 2026 revenue: $26.0 million, up 99% from $13.1 million in Q1 2025.
Product revenue grew 133% year-over-year to $21.3 million; consumables revenue up 178% to $14.0 million.
Gross profit: $14.5 million (56% margin), up from $6.4 million (49% margin) in Q1 2025.
Net loss: $21.3 million, including $8.6 million loss on convertible note remeasurement, compared to $7.7 million in Q1 2025.
Cash, cash equivalents, and restricted cash at March 31, 2026: $69.5 million.
Outlook and guidance
Management expects continued operating losses as investments in R&D, manufacturing, and commercialization increase.
Full-year 2026 stock-based compensation expected to be $13–15 million.
Cash from IPO and existing reserves expected to fund operations for at least the next 12 months.
- IPO targets $133M to scale advanced proteomics platform amid rapid growth and ongoing losses.ALMR
Registration filing16 Apr 2026 - IPO targets $133.2M to scale proteomics platform, expand R&D, and pursue diagnostics.ALMR
Registration filing13 Apr 2026 - High-growth proteomics firm targets IPO to fund expansion and R&D amid strong market demand.ALMR
Registration filing30 Mar 2026
Next Alamar Biosciences earnings date
Next Alamar Biosciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)